Paweł Domosławski

Prof. Paweł Domosławski


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2010
Verified
Journal Article
Closed access
AKAnna Królicka
Anna Królicka
CKChristopher Kobierzycki
Christopher Kobierzycki
Bartosz PulaBartosz Pula
Bartosz Pula
MPMarzena Podhorska-Okołów
Marzena Podhorska-Okołów
APAleksandra Piotrowska
Aleksandra Piotrowska
Piotr DziegielPiotr Dziegiel
Piotr Dziegiel

10 April 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
Aleksandra KuzanAleksandra Kuzan
Aleksandra Kuzan
EKEmilia Królewicz
Emilia Królewicz
KNKarolina Nowakowska
Karolina Nowakowska
KSKamilla Stach
Kamilla Stach
Krzysztof KaliszewskiKrzysztof Kaliszewski
Krzysztof Kaliszewski
IKIrena Kustrzeba-Wójcicka
Irena Kustrzeba-Wójcicka
The patho-mechanism of changes in the thyroid gland, including carcinogenesis, is a complex process, which involves oxidative stress. The goal of our investigation was to verify the extent of stress in the thyroid gland related to glycation. The study samples were comprised of blood sera, thyroid, and adipose tissue sections probed from 37 patients diagnosed with thyroid cancers and goiter. Using immuno-enzymatic and fluorometric assays we analyzed the content of advanced glycation end-products (AGEs), pentosidine, receptors for advanced glycation end-products (RAGE), scavenger receptor class (SR)-A, SR-B, glutathione, malondialdehyde and nitric oxide synthase. In addition to classic AGEs, a recent study detected the melibiose-derived glycation (MAGE) product. We demonstrated the presence of AGEs, MAGE and their receptors of the RAGE and SR-A. In addition, in the control samples of thyroid glands SR-B groups were detected as well as of pathological groups without noticeable tendency to antigen concentration in the area of carcinogenesis. Fluorescent AGEs correlate positively with glutathione, which supports the assumption that glycation stress leads to augmentation of oxidative stress and increase of the intensity of antioxidant mechanisms.

19 August 2008
Verified
Journal Article
Closed access
WBWiktor Bednarz
Wiktor Bednarz
PCPiotr Czopnik
Piotr Czopnik
BWBeata Wojtczak
Beata Wojtczak
RORobert Olewiński
Robert Olewiński
PDPaweł Domosławski
Paweł Domosławski
JSJan Spodzieja
Jan Spodzieja

8 March 2013
Verified
Journal Article
Closed access
PDPaweł Domosławski
Paweł Domosławski
TLTadeusz Lukieńczuk
Tadeusz Lukieńczuk
Krzysztof KaliszewskiKrzysztof Kaliszewski
Krzysztof Kaliszewski
KSKrzysztof Sutkowski
Krzysztof Sutkowski
RWRomualda Wojczys
Romualda Wojczys
BWBeata Wojtczak
Beata Wojtczak

30 November 2018 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
PDPaweł Domosławski
Paweł Domosławski
Bartosz PulaBartosz Pula
Bartosz Pula
MOMateusz Olbromski
Mateusz Olbromski
BWBeata Wojtczak
Beata Wojtczak
TLTadeusz Lukienczuk
Tadeusz Lukienczuk
Piotr DziegielPiotr Dziegiel
Piotr Dziegiel
Background/Aim: The expression of metallothionein I/II (MT-I/II) was examined in thyroids of Graves' disease (GD) and nodular goiter (NG) patients to determine its role as a potential marker of proliferation and autoimmune inflammation in the thyroid. Patients and Methods: MT-I/II and Ki-67 antigen expression was studied using immunohistochemistry in 72 GD and 24 NG patients. Results: MT-I/II expression was noted in the cytoplasm and nuclei of thyrocytes of GD and NG patients. Cytoplasmic and nuclear MT-I/II expression correlated strongly with GD (r=0.51; p<0.0001) and NG (r=0.50; p=0.0137). Cytoplasmic MT-I/II expression was significantly higher in GD (mean IRS 9.24±2.36) than in NG (mean IRS 7.13±2.51; p=0.0006) and correlated positively with Ki-67 antigen expression (r=0.28; p=0.0165). Nuclear MT-I/II expression was elevated in GD (mean 3.53±0.65) in comparison to NG (mean 2.96±0.86; p=0.028). Conclusion: MT-I/II may be a potential marker of GD in the thyroid and may be potentially involved in thyrocytes' proliferation.

1 August 2003
Verified
Journal Article
Closed access
TŁTadeusz Łukieńczuk
Tadeusz Łukieńczuk
BBBolesław Bojarski
Bolesław Bojarski
PJPrzemysław Jaźwiec
Przemysław Jaźwiec
ZFZdzisław Forkasiewicz
Zdzisław Forkasiewicz
BKBartłomiej Kedzierski
Bartłomiej Kedzierski
PDPaweł Domosławski
Paweł Domosławski